+91 7986995600
seclislabs@gmail.com
Contact Us
Respiratory Therapy: Antiallergics, Antipyretics, Anti Cold/Cough

MILDRESP LS

Ambroxol HCl 7.5mg + Levosalbutamol 0.25mg + Guaiphenesin per mL (Drops)

Dosage Form Drops
Packing 15mL (with carton and dropper)
MRP ₹65
Prescribed By Paediatrician, Pulmonologist, General Physician, ENT Specialist, Neonatologist

Quick Facts

Storage Below 30°C; Shake before use; Schedule: H; MRP: ₹65; 15mL with dropper; Neonatal use

Key Benefits

01
Drops format — precise small-volume dosing for neonates and young infants
02
Levosalbutamol — safe bronchodilator for the youngest patients
03
Graduated dropper for accurate dose delivery
04
Affordable ₹65 for the neonatal respiratory care segment
05
With carton and dropper for complete presentation

Mechanism of Action

Same triple-action formula as MILDRESP LS syrup but in a concentrated drops format for neonates and very young infants — lower volume, precise dosing with a graduated dropper. Ambroxol thins mucus, Levosalbutamol opens airways, Guaiphenesin loosens secretions.

Indications

Neonatal and infant respiratory congestion with cough, productive cough in infants below 2 years, and young children requiring small-volume precise respiratory medication.

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why MILDRESP LS?

The infant drops formulation of MILDRESP LS — completing the brand across neonates (drops), children (junior syrup), and adults (100mL syrup).

Interested in franchising MILDRESP LS?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top